VANGUARD GROUP INC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$299,669,921
-20.0%
5,967,143
+0.6%
0.01%
-22.2%
Q2 2023$374,739,786
+41.7%
5,929,427
+0.9%
0.01%
+28.6%
Q1 2023$264,493,691
+4.6%
5,878,944
+1.8%
0.01%0.0%
Q4 2022$252,978,917
-32.2%
5,774,456
+2.0%
0.01%
-36.4%
Q3 2022$373,009,000
+31.5%
5,661,103
+0.8%
0.01%
+37.5%
Q2 2022$283,706,000
-19.6%
5,616,811
+1.7%
0.01%0.0%
Q1 2022$352,941,000
-40.5%
5,525,060
-0.2%
0.01%
-38.5%
Q4 2021$592,722,000
+3.3%
5,533,771
-0.9%
0.01%
-7.1%
Q3 2021$574,001,000
+17.3%
5,583,132
+0.3%
0.01%
+16.7%
Q2 2021$489,544,000
-8.7%
5,565,543
+0.9%
0.01%
-20.0%
Q1 2021$536,111,000
-7.8%
5,513,829
+6.3%
0.02%
-11.8%
Q4 2020$581,667,000
+30.9%
5,186,512
+8.2%
0.02%
+13.3%
Q3 2020$444,476,000
+15.6%
4,794,780
-2.7%
0.02%
+7.1%
Q2 2020$384,479,000
+34.8%
4,929,210
+1.1%
0.01%
+16.7%
Q1 2020$285,186,000
-18.5%
4,876,660
+11.6%
0.01%0.0%
Q4 2019$349,919,000
+9.7%
4,367,984
+0.6%
0.01%0.0%
Q3 2019$318,958,000
-21.0%
4,341,335
+1.4%
0.01%
-20.0%
Q2 2019$403,861,000
+27.4%
4,281,362
+8.1%
0.02%
+25.0%
Q1 2019$316,958,000
+54.0%
3,959,505
+3.7%
0.01%
+33.3%
Q4 2018$205,826,000
-29.4%
3,817,962
+2.2%
0.01%
-18.2%
Q3 2018$291,584,000
+26.8%
3,735,390
+3.1%
0.01%
+10.0%
Q2 2018$230,015,000
-25.8%
3,623,418
+7.1%
0.01%
-28.6%
Q1 2018$310,134,000
+24.0%
3,382,055
+2.0%
0.01%
+27.3%
Q4 2017$250,129,000
+85.6%
3,316,928
+71.5%
0.01%
+83.3%
Q3 2017$134,758,000
+87.8%
1,934,229
+36.6%
0.01%
+50.0%
Q2 2017$71,746,000
+47.0%
1,415,963
+16.0%
0.00%
+33.3%
Q1 2017$48,806,000
+91.8%
1,220,446
+34.5%
0.00%
+200.0%
Q4 2016$25,448,000
+20.3%
907,265
+27.3%
0.00%0.0%
Q3 2016$21,161,000
+84.3%
712,475
+25.7%
0.00%0.0%
Q2 2016$11,481,000
+20.5%
566,995
+7.4%
0.00%0.0%
Q1 2016$9,526,000
-28.3%
527,742
+4.6%
0.00%0.0%
Q4 2015$13,287,000
-92.7%
504,456
-89.9%
0.00%
-85.7%
Q3 2015$181,709,000
+3610.6%
4,981,966
+2594.8%
0.01%
Q2 2015$4,897,000184,8710.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders